(NASDAQ:TMCI), PONTE VEDRA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities, today announced that John T. Treace, Chief Executive Officer, will present at the 44th Annual J.P. Morgan […]
(NASDAQ:IVF), SARASOTA, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) — INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced changes to its executive leadership team to align its human resources with the Company's growth strategy
(NYSE:DVN), OKLAHOMA CITY, Dec. 30, 2025 (GLOBE NEWSWIRE) — Devon Energy Corp. (NYSE: DVN) today announced Clay Gaspar, President and CEO will participate in a panel at the Goldman Sachs Energy, Cleantech, & Utilities Conference. The panel is scheduled for 2:00 p.m. Central time (3:00 p.m. Eastern time) on Tuesday, January 6, 2026 and will
(NASDAQ:ADPT), SEATTLE, Dec. 30, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco,
(NASDAQ:MDLN), NORTHFIELD, Ill., Dec. 30, 2025 (GLOBE NEWSWIRE) — Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the J.P. Morgan Healthcare Conference in San Francisco, Calif., on Tuesday, January 13, 2026, at 3:00 pm Pacific Time. The presentation will
(NASDAQ:HERZ), MIAMI BEACH, Fla., Dec. 30, 2025 (GLOBE NEWSWIRE) — Herzfeld Credit Income Fund, Inc. (NASDAQ: HERZ) (the “Fund”) today announced that the Fund has made the following year-end distribution: Declaration Date Ex-Date Record Date Payment Date Per Share 11/10/2025 12/31/2025 11/21/2025 12/30/2025 $0.6867 The distribution for stockholders has been paid in cash or shares
(NASDAQ:CBLL), SUNNYVALE, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) — CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that Jane Chao, Ph.D., CEO and Co-founder, will present at the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco. The
(NASDAQ:RARE), NOVATO, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) today announced that it has completed the rolling submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA), seeking approval for DTX401 AAV gene therapy (pariglasgene brecaparvovec) as a treatment for Glycogen Storage Disease Type Ia
(NASDAQ:PACB), MENLO PARK, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026, at 10:30 AM PT (1:30 PM ET) in San Francisco, California. A live
(NYSE:KEX), HOUSTON, Dec. 30, 2025 (GLOBE NEWSWIRE) — Kirby Corporation (“Kirby”) (NYSE: KEX) will announce its 2025 fourth quarter results at 6:00 a.m. Central Standard Time (“CST”) on Thursday, January 29, 2026. This announcement will be followed by an earnings conference call webcast at 7:30 a.m. CST. For listeners who wish to participate in the